The largest community of pharma leaders

My Vape Order Announces Submission of FDA Premarket Tobacco Application for AIR FACTORY® e-liquids

IRVINE, Calif.–()–My Vape Order, Inc. (MVO), a trusted provider of nicotine e-liquid products marketed under the AIR FACTORY® brand, has announced its submission of a bundled Premarket Tobacco Application (PMTA) to the U.S. Food and Drug Administration (FDA) for its suite of 72 AIR FACTORY® products, including both freebase and salt nicotine formulations in a variety of nicotine strengths.

The AIR FACTORY® PMTA submission was electronically filed with FDA on September 3, 2020. Included with the application were robust scientific data including independently-conducted toxicological risk assessments for the submitted products, as well as thorough research findings intended to establish the AIR FACTORY® products as appropriate for the protection of public health. The company’s PMTA filing coincides with the launch of re-designed product packaging for the AIR FACTORY® brand and the implementation of additional safeguards through the company’s B2B and B2C websites to further the company’s commitment to preventing youth exposure to tobacco and nicotine products.

MVO’s CEO, Kyle Godfrey, commented, “Submission of the AIR FACTORY® PMTA marked the culmination of years of planning and hard work for the MVO team and our valued partners. MVO is honored to be a leader in the vape industry, and is proud to provide consumers of tobacco and nicotine products a quality line of e-liquids that consumers can trust and enjoy.” Updates regarding FDA’s PMTA review for the company’s products will be forthcoming.


Recent Articles

Sperm Bank Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Androcryos and Cryos International-Denmark ApS | Technavio

LONDON--(BUSINESS WIRE)-- #GlobalSpermBankMarket--The Global Sperm Bank Market will grow by $...

Global Hereditary Transthyretin Amyloidosis (hATTR) Competitive Landscape, Market Insights, Epidemiology and Forecast 2017-2020 & 2030 –

DUBLIN--(BUSINESS WIRE)--The "Hereditary Transthyretin Amyloidosis (hATTR) - Competitive Landscape, Market Insights,...

Strive Health Welcomes David Thornton as Chief People Officer

DENVER--(BUSINESS WIRE)-- #executiveteam--Leading specialized kidney care company Strive Health today announced...

Accenture Puts Data Science to Work for Pediatric Leukemia Research

NEW YORK--(BUSINESS WIRE)--Accenture has built a data and analytics approach to...

FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

CLEVELAND--(BUSINESS WIRE)---- $ATHX #ARDS--MultiStem is the only cell therapy program for...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.